DRI Healthcare Trust (TSE:DHT.UN) Stock Rating Lowered by Raymond James

DRI Healthcare Trust (TSE:DHT.UNGet Free Report) was downgraded by investment analysts at Raymond James from a “strong-buy” rating to an “outperform” rating in a research report issued to clients and investors on Tuesday, BayStreet.CA reports. They presently have a C$24.00 price objective on the stock. Raymond James’ target price would indicate a potential upside of 95.60% from the stock’s previous close.

Several other equities research analysts have also commented on the stock. CIBC lifted their price target on shares of DRI Healthcare Trust from C$19.50 to C$20.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 8th. Canaccord Genuity Group cut their price target on shares of DRI Healthcare Trust from C$19.50 to C$19.00 and set a “buy” rating on the stock in a research note on Wednesday, May 8th. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of C$19.14.

Read Our Latest Stock Report on DRI Healthcare Trust

DRI Healthcare Trust Stock Up 43.2 %

TSE:DHT.UN opened at C$12.27 on Tuesday. The company has a 50 day moving average price of C$15.03 and a 200 day moving average price of C$14.92. DRI Healthcare Trust has a fifty-two week low of C$10.21 and a fifty-two week high of C$17.43.

About DRI Healthcare Trust

(Get Free Report)

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

Recommended Stories

Analyst Recommendations for DRI Healthcare Trust (TSE:DHT.UN)

Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.